Lindab (OM:LIAB) Q3 Results Hint At A Margin Recovery Ceiling

Lindab International came into this Q3 2026 report with its shares at SEK131.5, after a steady 3‑month climb and a reputation as a solid ventilation and building products play with a valuation angle. The fresh numbers tell a more nuanced story. Basic earnings per share landed at 2.42 SEK and net income reached 187 million SEK, helped by an 8.7% adjusted operating margin that recovered from Q2 but still sat below last year. That mix of improving profitability and lingering margin pressure is what the market is really reacting to today.

We like the underlying business at Lindab International, but we are concerned that margins still lag last year. If you are looking for sturdier profitability profiles in similar ideas, including ventilation and building related suppliers, check out the list of solid balance sheet and fundamentals stocks (204 results)

Q3 2026 Earnings Summary

• Revenue (Q3 2026 vs. Q3 2025): 3,237 million SEK vs. 3,253 million SEK (slight decline in top line)
• Net Income (Q3 2026 vs. Q3 2025): 187 million SEK vs. 400 million SEK (profit roughly halved year on year)
• Basic EPS (Q3 2026 vs. Q3 2025): 2.42 SEK vs. 5.19 SEK (earnings per share fell sharply versus the prior period)
• Adjusted Operating Margin (Q3 2026 vs. Q3 2025): 8.7% vs. 9.7% (profitability softer than last year despite quarter on quarter recovery)

Pricing is improving margins, but profitability still trails last year. Ask Charlie what’s really driving Lindab’s margin recovery.

Lindab International: Testing The Dividend-Support Story

The bullish view hangs on Lindab International using a steady dividend as a backbone for total returns even while profitability heals.

"LIAB: Dividend Policy Will Support Future Returns Despite Margin Headwinds"

Q3 results partly line up with that idea. Earnings per share of 2.42 SEK and net income of 187 million SEK still cover a typical quarterly payout for a building products group of this size, and leverage at 2.8x net debt to EBITDA remains within the stated ceiling. At the same time, the adjusted operating margin of 8.7% trails last year, so the income cushion for future distributions has thinned compared with the prior Q3.

One Narrative disagrees with today's price. → See where this Narrative says Lindab International should trade.

Lindab International Margins Still Shadowed By Flat Markets

The bearish view argues that weak end markets and cost inflation will keep Lindab International’s recovery on a tight leash.

"Management guidance that the broader European ventilation market is likely to stay relatively flat through 2026, with only some growth in 2027, points to limited volume support for these higher value lines. This can cap revenue and earnings contributions from the mix shift."

Q3 organic sales growth of 2%, with Ventilation Systems at 1%, fits that concern. Margin repair to 8.7% helps, yet still trails last year and arrived with softer cash flow and leverage nudging up to 2.8x net debt to EBITDA. The mix shift is working, but not decisively disproving the caution.

Hunt For Quiet Value Disconnects

Lindab International reports a mixed quarter that leaves the investment case unresolved. The real opportunity sits in studying stocks that could be undervalued before expectations reset.

• Company 1 - 26% below our estimate - pivots from traditional shipbuilding to integrating underwater technology and digital systems into defense service contracts.
• Company 2 - 44% below our estimate - expands animal health formulations and contract development work while moving mature human drugs to backward integrated manufacturing.
• Company 3 - 33% below our estimate - grows fee income by raising capital into tax efficient funds and regional private equity targeting real asset infrastructure.

That is three of the list. See every one of the 192 undervalued companies on it →

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com